References
- Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab 1996; 9:3147–51
- Nestler JE. Dehydroepiandrosterone: fountain of youth or snake oil? Endocrinologist 1977;7:423–8 Vermeulen A. Physiopathology of dehydroepi- androsterone and its sulfate. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:13–34
- Baulieu EE. Neuroactive neurosteroids: dehydro- epiandrosterone and dehydroepiandrosterone sulfate. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:35–68
- Labrie F, Belanger A, Luu-The V, Simard J, Lin SX, Cusan L, Labrie C. Role DHEA transform- ation into androgens and estrogens in peripheral interactive tissues In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing, 1999:69–104
- Pashiko L, Schwarts AG. Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha- fluoro-5-androsten-17-one in diabetic mice. Diabetes 1996;42:1105–8
- Svec F, Hilton CW, Qright BE. The effect of DHEA given chronically to Zucker rats. Proc Soc Exp Biol Med 1995;209:92–7
- Bednarek-Tupikowska G, Milewicz A, Kossowska B, Bohdanowicz-Pawlak A, Sciborski R. The influence of DHEA on serum lipids, insulin and sex hormone levels in rabbits with induced hypercholesterolemia. Gynecol Endocrinol 1995;9:23–8
- Arlt W, Callies F, van Vlijmen J. Dehydro- epiandrosterone replacement in women with hypopituitarism. N Engl J Med 1999; 341:1013–20Hunt P, Gurnell E, Huppert F. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85:4650–6
- Milewicz A, JVdrzejuk influence of DHEA treatment on bone turnover parameters bone mineral density in postmenopausal women. In Genazzanied. Proceedings of the European Society for Gynecologic and Obstetric Investigation. Rome: CIC Edizioni Internazionali, 2002:416–20
- Svec F, Porter J. Dehydroepiandrosterone in metabolic diseases. In Thijssen JH, Nieuwenhuyse H, eds. DHEA a Comprehensive Review. Carnforth, UK: Parthenon Publishing,1999:105–26
- Arlt W, Callies F, Koehler I, van Vlijmen JCh, Fassnacht M, Strasburger ChJ, et al. Dehydro- epiandrosterone supplementation in healthy men with an age-related decline of dehydroepi- androsterone secretion. J Clin Endocrinol Metab 2001;6:4686–92
- Legrain S, Massien Ch, Lahlou N, Roger M, Debuire B, Diquet B, et al. Dehydroepiandro- sterone administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208–17
- Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med 1996;315:1519–24
- Nestler JE, Barlancini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1998;66:57–61
- Morales AJ, Lolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advanced age. J Clin Endocrinol Metab 1994;78:1360–7
- Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women potential remedial effects. Ann NY Sci 1995;443:128–42
- Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li HE, et al. Dehydroepiandrosterone inhibits human vascular smooth muscle cell prolif- eration independent of ars and ers. J Clin Endocrinol Metab 2000;87:176–81
- Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to G alpha(i2,3). J Biol Chem 2002;14:21379–88
- Aleksandersen P, Haarabo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996; 125:1–13
- Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, et al. Between plasma testos- terone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab 1997;82:682–5
- Coleman DL. Therapeutic effects of dehydro- epiandrosterone treatment in rats with diet- induced obesity. Prog Clin Biol Res 1988;265:161–75
- Buffingtom CK, Pourmotabbed G, Kitabchi AE. Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone. Am J Med Sci 2000;306:320–4
- Herrington DMN, Gordon GB, Aschuff SC. Plasma dehydroepiandrosterone and dehydroepi- androsterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862–70